Title
Physician Collaboration with Pharmacists on Drug Therapy Management: Physician Attitudes and Intentions,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Payment Option
Pharmacistphysician collaboration has been shown to improve the safety and costeffectiveness of drug therapy, however, it occurs relatively infrequently in the community setting, with respect to drug therapy management. This book provides information regarding family physician attitudes towards and readiness to collaborate with community pharmacists on drug therapy management. We developed a survey instrument utilizing the Transtheoretical Model of Behaviour Change, and administered it to a random sample of 848 family physicians in Ontario, Canada. We found that collaborative relationships between pharmacists and physicians were generally underdeveloped. Systemrelated barriers, including pharmacists' lack of patient information, were highlighted by physicians as particularly problematic for collaborative relationship development. Our analysis sheds light on the predictors of physician readiness to collaborate with pharmacists, and provide direction for policy makers and health professionals interested in developing collaborative working relationship with physicians.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.